← Eichor
Condition: Cerebral Metastases Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cerebral Metastases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
Phase 1/Phase 2 · 10 location(s) · Eikon Therapeutics · NCT06907043NTS-WBRT in Brain Metastases
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT05013892Multisite Advancement of Research on Chronic Posttraumatic Headache
NA · 8 location(s) · The University of Texas Health Science Center at San Antonio · NCT05620719Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT05911230a Feasibility Study of iHD-SRT for BM
NA · 1 location(s) · Ruijin Hospital · NCT06231186Prospective Cohort Study of Intracerebral Hemorrhage
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04707105A Clinical Trial of Furmonertinib Combined With Anlotinib as First-line Treatment for Advanced NSCLC With EGFR-sensitive
Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT06945705Osteopathic Manipulative Treatment vs Physiotherapy in Cervicocranial Dysfunction
NA · 1 location(s) · Burim Peli · NCT07555873Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippo
Phase 3 · 231 location(s) · NRG Oncology · NCT04804644Multi-disciplinary Care for Brain Metastases
NA · 1 location(s) · University of Vermont Medical Center · NCT06280300Neutrophil to Lymphocyte Ratio and Postdural Headache
Phase N/A · 1 location(s) · Istinye University · NCT07075874A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Br
Phase 1 · 6 location(s) · A2A Pharmaceuticals Inc. · NCT06136884Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases
NA · 10 location(s) · Susanne Rogers · NCT05124236Effect of Ultrasound-Guided Dry Needling Targeting Rectus Capitus Posterior Major on Individuals With Headaches
NA · 1 location(s) · Texas Tech University Health Sciences Center · NCT07309874Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases
Phase N/A · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07008287Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05704647Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases
Phase 2 · 3 location(s) · Maastricht University Medical Center · NCT06401824Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis Afte
Phase 3 · 6 location(s) · The Netherlands Cancer Institute · NCT06888817AI-assisted Diagnosis of Malignant Brain Tumors
Phase N/A · 2 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07198256A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Mon
Phase N/A · 13 location(s) · Hoffmann-La Roche · NCT07455136Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors
Phase N/A · 1 location(s) · Pietro Mortini, MD, Prof. · NCT05831631Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Phase 2 · 4 location(s) · Henry M. Jackson Foundation for the Advancement of Military · NCT05049057Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy
Phase 2 · 1 location(s) · University of Vermont Medical Center · NCT06974370Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Phase 2 · 2 location(s) · Brigham and Women's Hospital · NCT048999083'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090Ischemic Compression Technique Versus Jones Technique in Cervicogenic Headache Patients
NA · 1 location(s) · Riphah International University · NCT06875869China Headache and Vertigo Registry Study
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04939922Neoadjuvant Stereotactic Radiotherapy for Brain Metastasis
NA · 4 location(s) · University Hospital Ostrava · NCT06933199Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastase
Phase 2 · 1 location(s) · Medical University of Vienna · NCT05866432Comparison of the Eficacy of Mulligan Mobilization and Myofascial Release in Patients With Cervicogenic Headache
NA · 1 location(s) · Konya Beyhekim Training and Research Hospital · NCT07508410
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.